Rule 2.9 Announcement

Oxford Biomedica plc has issued a Rule 2.9 announcement confirming that as of the close of business on 21 January 2026, its issued share capital comprised 120,809,814 ordinary shares of £0.50 each, with no shares held in treasury. This disclosure is made in accordance with the City Code on Takeovers and Mergers and provides essential information regarding the company's share structure.